Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 23, 2010

View Archived Issues

Kalypsys claims new GPR119 receptor agonists

Pulmagen Therapeutics discovers new inhibitors of neutrophil elastase

Boehringer Ingelheim discovers novel chymase inhibitors

Phosphoprofiling approach identifies drug-specific biomarkers of PI3K pathway inhibition

Meta-analysis reveals potential link between ARBs and onset of cancer

GCC-2680 shows promise as obesity therapeutic based on preclinical data

Amsterdam Molecular Therapeutics provides update on Glybera MAA

Anchor Therapeutics secures funds to advance pepducin drug candidates

Bioniche provides development update on Urocidin in bladder cancer

Bolder BioTech receives grant to study IL-11 analogue for acute radiation syndrome

Protalex treats first patient in phase Ib PRTX-100 trial in RA

SkyePharma regains U.S. rights to Flutiform for asthma

ADDF funds Cognition Therapeutics to advance AD candidate

ISCO provides update on stem cell-based eye care programs

Scientists link clozapine-induced myocarditis to obesity, creatinine kinase and C-reactive protein

FDA extends review of Acetadote sNDA for non-acetaminophen acute liver failure

EpiCept receives refusal to file letter from FDA for Ceplene NDA

Scientists identify new pathway of tricarboxylic acid metabolism in P. falciparum

Precedex IV 200 mcg approved for long-term use in Japan

New DGAT-1 inhibitors claimed by Banyu Pharmaceutical

Pfizer discloses new inhibitors of DGAT-1

FDA advisory committee votes against use of JZP-6 for fibromyalgia

FDA continues safety review of Stalevo and possible increased cardiovascular risk

University of Pittsburgh receives donation for stem cell research on corneal scarring

GSK begins phase III trials of herpes zoster vaccine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...